Apostrophe, a skin care telehealth brand headquartered in the Bay Area, is shutting down after almost four years under the ...

Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...

with services spanning from skin care and hair loss to anxiety and erectile dysfunction. This review examines its erectile dysfunction (ED) services, looking closely at what Hims offers its users ...

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operations ...

The company — which Hims & Hers acquired in 2021 — canceled ... and receive support for the next 30 days. Growth in the skin care category may be slowing, according to a recent report from ...

We evaluate services for consistency with standards of care and best ... Dudum commented on his skin issues. Focused on full-service telemedicine for men’s health, Hims provides digital ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Hims & Hers Health Inc. has acquired a California ... Other peptides are commonly found in over-the-counter supplements and skin-care products, with some being promoted for supposed longevity ...

Changes are afoot in the teledermatology space. As Hims & Hers shutters Apostrophe, the teledermatology specialist it ...

Hims & Hers also offers treatments for skin care, mental health, sexual health and hair care. Revenue for non-GLP-1 products increased 43% to $1.2 billion for the full year, "meeting our previous ...

The brand, which entered Target just two years ago, will no longer accept orders on its website after March 24.